| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO | CEO And President
3 companies
Erck Stanley C is a Director at MAXCYTE, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 90 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | MXCT Maxcyte, Inc. | - | Buy | 100,000 | $1.37 | $137,220.00 | +33.5% | +12.3% | - | |
| Nov 1, 2024 | MXCT Maxcyte, Inc. | Director | Sale+OE | 47,689 | $3.72 | $177,403.08 | -15.1% | +21.8% | -59.2% | |
| Oct 2, 2024 | MXCT Maxcyte, Inc. | Director | Sale+OE | 47,689 | $3.75 | $178,751.93 | -8.1% | +11.2% | -57.0% | |
| Sep 4, 2024 | MXCT Maxcyte, Inc. | Director | Sale+OE | 47,689 | $4.02 | $191,655.19 | -8.1% | -8.2% | -65.1% | |
| Oct 4, 2021 | NVAX Novavax Inc | President And CEO | Sale+OE | 42,829 | $176.15 | $7,544,194.71 | -8.8% | -19.8% | -89.1% | |
| Oct 1, 2021 | NVAX Novavax Inc | President And CEO | Sale+OE | 49,000 | $175.10 | $8,580,063.84 | -4.5% | -14.7% | -90.0% | |
| Jul 2, 2021 | NVAX Novavax Inc | President And CEO | Sale+OE | 105,179 | $214.38 | $22,548,579.01 | -10.6% | -4.6% | -73.7% | |
| Nov 16, 2020 | NVAX Novavax Inc | President And CEO | Sale+OE | 52,316 | $90.65 | $4,742,666.96 | -16.6% | - | - | |
| Oct 1, 2020 | NVAX Novavax Inc | President And CEO | Sell | 12,233 | $110.23 | $1,348,417.52 | -4.5% | - | - | |
| Sep 29, 2020 | NVAX Novavax Inc | President And CEO | Sale+OE | 29,112 | $109.95 | $3,200,722.15 | -4.5% | - | - |